Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Brief Summary: This study will be a prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter trial of postmenopausal subjects with an intact uterus.


Options:
A: Arm Label: Placebo transdermal three 90 μL sprays; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo transdermal three 90 μL sprays | Arm Label: Placebo transdermal two 90 μL sprays; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo transdermal two 90 μL sprays | Arm Label: Placebo transdermal one 90 μL spray; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo transdermal one 90 μL spray | Arm Label: Estradiol transdermal three 90 μL sprays; Type: ACTIVE_COMPARATOR; Interventions: Drug: Estradiol transdermal three 90 μL sprays | Arm Label: Estradiol transdermal two 90 μL sprays; Type: ACTIVE_COMPARATOR; Interventions: Drug: Estradiol transdermal spray, two 90 μL sprays | Arm Label: Estradiol transdermal one 90 μL spray; Type: ACTIVE_COMPARATOR; Interventions: Drug: Estradiol transdermal one 90 μL spray | Intervention Type: DRUG; Name: Estradiol transdermal one 90 μL spray; Assigned to Arm(s): Estradiol transdermal one 90 μL spray | Intervention Type: DRUG; Name: Estradiol transdermal spray, two 90 μL sprays; Assigned to Arm(s): Estradiol transdermal two 90 μL sprays | Intervention Type: DRUG; Name: Estradiol transdermal three 90 μL sprays; Assigned to Arm(s): Estradiol transdermal three 90 μL sprays | Intervention Type: DRUG; Name: Placebo transdermal two 90 μL sprays; Assigned to Arm(s): Placebo transdermal two 90 μL sprays | Intervention Type: DRUG; Name: Placebo transdermal three 90 μL sprays; Assigned to Arm(s): Placebo transdermal three 90 μL sprays | Intervention Type: DRUG; Name: Placebo transdermal one 90 μL spray; Assigned to Arm(s): Placebo transdermal one 90 μL spray
B: Arm Label: Treatment 1; Type: EXPERIMENTAL; Interventions: Drug: Estradiol, Drug: Progesterone, Drug: Placebo | Arm Label: Treatment 2; Type: EXPERIMENTAL; Interventions: Drug: Estradiol, Drug: Progesterone, Drug: Placebo | Arm Label: Treatment 3; Type: EXPERIMENTAL; Interventions: Drug: Estradiol, Drug: Progesterone, Drug: Placebo | Arm Label: Treatment 4; Type: EXPERIMENTAL; Interventions: Drug: Estradiol, Drug: Progesterone, Drug: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Estradiol; Assigned to Arm(s): Treatment 1, Treatment 2, Treatment 3, Treatment 4 | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Treatment 1, Treatment 2, Treatment 3, Treatment 4 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo, Treatment 1, Treatment 2, Treatment 3, Treatment 4
C: Intervention Type: DRUG; Name: estradiol gel; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: bioidentical hormone (Biest) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: bioidentical hormone (Biest) | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: bioidentical hormone (Biest) | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: bioidentical hormone (Vivelle-Dot) | Intervention Type: DRUG; Name: bioidentical hormone (Biest); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: bioidentical hormone (Biest); Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: bioidentical hormone (Biest); Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: bioidentical hormone (Vivelle-Dot); Assigned to Arm(s): 4

Answer: B